Acurx Pharmaceuticals to discuss third-quarter 2026 results on November 12

ACXP•2026-10-26

Acurx Pharmaceuticals will discuss its third-quarter 2026 financial results and provide a business update on a conference call on November 12, 2026.

1. Conference call

Acurx Pharmaceuticals said it will discuss third-quarter 2026 financial results and provide a business update on a conference call on November 12, 2026.

Acurx Pharmaceuticals to discuss third-quarter 2026 results on November 12

1. Conference call

Related News

Star Equity Holdings expands energy services division with machine shop acquisition in Vernal, Utah

Consolidated Water sets third-quarter results conference call

Azitra presents ATR-COSF skin study results at BIO-Europe

PSB Holdings Q3 net interest income rises on lower funding costs

EU accepts Temu plan to remedy Digital Services Act breach